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Editorial
Direct percutaneous valve replacement: the next step?*Percutaneous valve replacement has been advocated for
quite some time and a PubMed search with the term
‘percutaneous valve replacement’ provides at the time of
writing 356 hits out of which about 25 focus on this
procedure [1–3,5,6]. Various routes for delivery of the
valved devices have been proposed mainly in function of the
target position of the implant [4]. In the clinical setting,
these include remote access through peripheral arteries or
veins for both, right (1) and left (2) sides. However, those of
us who are involved in endovascular aneurysm repair
(EVAR) know very well, that peripheral vascular access is a
major issue for insertion of larger introducer systems.
Although there are ways around the limited size admitted
for insertion through peripheral vessels, like trans-aortic
insertion [3] or in situ introducer sheath dilatation [7],
remote access has a number of other limitations. As a matter
of fact, valved stents inserted from the groin, have to travel
over a long endo-vascular path in order to reach the target
zone. The latter is preferably at the level of the annulus of
the native or prosthetic valve, which has to be replaced, in
order to achieve good sealing.
Long delivery systems, are not only cumbersome to
handle, but must be relatively flexible for steerability. This
in turn limits their resistance to torque, increases the risk of
kinking, provides more resistance to unloading, and makes
it delicate to keep the tip with the valved stent at a certain
position in reliable fashion if the blood streams at full flow.
Additional hurdles to percutaneous valve replacement with
remote access can be expected in the presence of access
vessel tortuosity and peripheral vascular disease, which are
frequent in elderly patients who might benefit most from an
expeditious procedure.
Of course orthotopic implantation of valved stents with
direct access to the heart is also feasible. Full sternotomy,
working heart, and trans-apical access have been used for
insertion of valved stents in pulmonary as well as aortic
positions. Direct access to the heart has a number of
advantages over remote access, including shorter delivery1010-7940/$ - see front matter q 2004 Elsevier B.V. All rights reserved.
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* Please read the corresponding How-to-do-it article on pp. 1044–6 of
this issue, to which this Editorial refers.systems, which accept almost any device diameter. This in
turn allows for implantation of superior devices (less need
for extremely thinned out components) as well as superior
delivery system tip control, improved precision of device
positioning, and overall ease of implantation.
On page 1044 of this issue, Malgorzata Pawelec-
Wojtalik and colleagues report on a hybrid approach for
percutaneous valve replacement based on trans-apical
insertion of a valved stent which can be realized either
through an epigastric or a thoracic mini-incision [8]. The
innovative step in their approach is not just a smaller skin
incision to access the apex of the heart through which a
sutureless valve can be delivered, but the concept of using a
closure device for sealing the orifice created in the wall of
the heart.
There are a number of issues to be resolved prior to
routine clinical application of the proposed approach. These
include per-procedural troubleshooting, determination of
device blow-out pressures, quantification and limitation of
blood-loss, back-up procedures, etc. However, direct access
percutaneous valve replacement may well be the next step,
in this rapidly evolving field of care.References
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